Literature DB >> 1529480

Human cytochromes P450: problems and prospects.

F J Gonzalez1.   

Abstract

Cytochromes P450 are a superfamily of haem-containing monooxygenases. In mammals, two general classes of P450s exist: six families involved in steroid and bile acid biosynthetic pathways of metabolism; four families containing numerous individual P450s, mainly responsible for metabolism of foreign compounds. Many of the latter P450s, particularly those in the CYP2 family, exhibit a large degree of inter- and intra-species variability in regulation and catalytic activities. From a practical standpoint, these variabilities suggest the need for careful characterization of P450 catalytic activities and determination of P450 expression levels in humans. Human P450-based in vitro systems are being developed to evaluate drug and carcinogen metabolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1529480     DOI: 10.1016/0165-6147(92)90107-h

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  54 in total

Review 1.  A survey of the literature (1995-1999) on the kinetics of drugs in camels (Camelus dromedarius).

Authors:  A A Alquarawi; B H Ali
Journal:  Vet Res Commun       Date:  2000-05       Impact factor: 2.459

2.  Pharmacological and toxicological significance of brain cytochromes P450.

Authors:  V Ravindranath
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

3.  Estrogen modulates transactivations of SXR-mediated liver X receptor response element and CAR-mediated phenobarbital response element in HepG2 cells.

Authors:  Gyesik Min
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

Review 4.  Biochemical applications of ultrathin films of enzymes, polyions and DNA.

Authors:  James F Rusling; Eli G Hvastkovs; Dominic O Hull; John B Schenkman
Journal:  Chem Commun (Camb)       Date:  2007-08-30       Impact factor: 6.222

Review 5.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 6.  Inhibition and induction of cytochrome P450 and the clinical implications.

Authors:  J H Lin; A Y Lu
Journal:  Clin Pharmacokinet       Date:  1998-11       Impact factor: 6.447

7.  Cytochrome P4502D6 genotype does not determine response to clozapine.

Authors:  M J Arranz; E Dawson; S Shaikh; P Sham; T Sharma; K Aitchison; M A Crocq; M Gill; R Kerwin; D A Collier
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

8.  The use of transgenic cell lines for evaluating toxic metabolites of carbamazepine.

Authors:  C R Valentine; J L Valentine; J Seng; J Leakey; D Casciano
Journal:  Cell Biol Toxicol       Date:  1996-06       Impact factor: 6.691

Review 9.  Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

Authors:  L L von Moltke; D J Greenblatt; J Schmider; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

10.  Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P4503A and glutathione-S-transferase.

Authors:  P Fritz; E Behrle; P Beaune; M Eichelbaum; H K Kroemer
Journal:  Histochemistry       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.